AVE.AX Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 08:10):
Our systems believe the stock currently is overvalued by -33.11% compare to its pairs and should correct downwards.

Stats
Tagesvolumen	1.45M
Durchschnittsvolumen	3.15M
Marktkapitalisierung	6.34M
EPS	$-0.000400 ( Q4 \| 2023-12-31 )
Nächstes Ertragsdatum	( $0 ) 2024-08-28
Last Dividend	$0.0154 ( 1997-05-19 )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACW.AX 34.78%

ADO.AX 0.00%

AGH.AX -4.17%

ANP.AX -4.92%

ATH.AX 0.00%

AVE.AX 0.00%

BIT.AX 2.70%

BNO.AX -10.00%

BOT.AX -5.48%

CAN.AX 0.00%

CPH.AX 0.00%

CSL.AX 0.02%

CTE.AX 8.77%

CUV.AX 0.85%

CYP.AX 1.72%

DXB.AX 0.00%

ECS.AX 0.00%

EOF.AX -6.25%

GSS.AX 1.41%

IDT.AX 0.00%

IMC.AX 0.00%

IMM.AX -11.94%

IMU.AX 5.56%

IXC.AX -10.45%

KZA.AX 9.59%

LCT.AX 7.14%

LGP.AX -9.52%

MSB.AX 1.02%

MVP.AX -1.22%

MXC.AX 2.44%

NEU.AX 3.15%

NOX.AX -2.94%

NSB.AX 2.56%

OCC.AX 0.00%

OPT.AX -2.78%

OSL.AX 0.00%

PAA.AX 0.00%

PAB.AX 0.00%

PAR.AX -1.92%

PBP.AX 0.00%

PIQ.AX -2.22%

PTX.AX -2.56%

PXS.AX 3.70%

PYC.AX 0.00%

RAC.AX 1.11%

RCE.AX 5.26%

SPL.AX 9.20%

TLX.AX 1.36%

VBS.AX 0.00%

Korrelation (AI algo v.1.1b): Overvalued: -33.11% $0.00266 paired level. (Der Algorithmus verfolgt in Echtzeit die Änderungen der am stärksten korrelierten Aktien und gibt eine sofortige Aktualisierung)

Avecho Biotechnology Ltd Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Avecho Biotechnology Ltd Finanzdaten

Annual	2023
Umsatz:	$473 551
Bruttogewinn:	$-222 490 (-46.98 %)
EPS:	$-0.00150

FY	2023
Umsatz:	$473 551
Bruttogewinn:	$-222 490 (-46.98 %)
EPS:	$-0.00150

FY	2022
Umsatz:	$1.13M
Bruttogewinn:	$793 118 (70.23 %)
EPS:	$-0.00130

FY	2021
Umsatz:	$1.06M
Bruttogewinn:	$677 486 (63.94 %)
EPS:	$-0.00324

Financial Reports:

No articles found.

Avecho Biotechnology Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Avecho Biotechnology Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.0154	1995-10-25
Last Dividend	$0.0154	1997-05-19
Next Dividend	$0	N/A
Payout Date	1997-06-06
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.0308	--
Avg. Dividend % Per Year	0.00%	--
Score	0.22	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2025-10-03)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.22

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
1995	$0	0.00%
1996	$0	0.00%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
19 May 1997	$0.0154	12 Mar 1997	20 May 1997	06 Jun 1997
25 Oct 1995	$0.0154	30 Jun 1995	31 Oct 1995	24 Nov 1995

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
EZL.AX	Dividend Royal	2024-02-02	Semi-Annually	24	11.64%	8.24
GRR.AX	Dividend Royal	2024-03-12	Semi-Annually	14	11.88%	7.99
RKN.AX	Dividend Royal	2023-08-31	Annually	22	15.73%	7.24
TWR.AX	Dividend King	2024-06-12	Annually	25	5.98%	7.21
YAL.AX	Dividend Royal	2024-03-12	Annually	7	12.76%	7.18
SHM.AX	Dividend Royal	2024-03-14	Semi-Annually	9	14.97%	7.14
HZN.AX	Dividend Royal	2024-04-18	Semi-Annually	4	18.99%	7.06
BHP.AX	Dividend Royal	2024-03-07	Semi-Annually	37	6.46%	6.97
CDD.AX	Ex Dividend King	2024-05-24	Annually	21	91.43%	6.79
KSL.AX	Dividend Royal	2024-03-05	Semi-Annually	9	9.58%	6.77

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-7.26	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.470	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.802	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	8.30	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.83	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	6.53	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0239	-1.500	9.60	-10.00	[0 - 0.6]
interestCoverageTTM	-298.85	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.00100	2.00	-0.000334	-0.000669	[0 - 30]
freeCashFlowPerShareTTM	-0.00100	2.00	-0.000502	-0.00100	[0 - 20]
debtEquityRatioTTM	0.0275	-1.500	9.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	-0.470	1.000	-10.00	-10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-9.69	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-18.16	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.0647	0.800	-2.90	-2.32	[0.5 - 2]
Total Score				-2.73

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.844	1.000	-0.287	0	[1 - 100]
returnOnEquityTTM	-0.802	2.50	-6.44	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00100	2.00	-0.000334	-0.00100	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00100	2.00	-0.000334	-0.000669	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0170	1.500	-3.45	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-6.72	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.55

Avecho Biotechnology Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Avecho Biotechnology Ltd

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.